Aqeel Kadri is a Partner at Hausfeld based in London. He is experienced in acting for clients across a range of contentious competition and State aid matters ; his experience includes cases in the energy, pharmaceutical, and technology sectors. He has extensive experience of representing clients in investigations and litigation relating to competition and State aid, including before the European Commission, EU General Court, European Court of Justice, and in the UK before the Competition and Markets Authority, Competition Appeal Tribunal, High Court, Court of Appeal and Supreme Court.
360
In anticipation of the wave of requests from stricken companies due to the COVID-19 outbreak for more long-term State support, on 8 May, the Commission extended the scope of its State aid Temporary Framework to allow Member States to take stakes in non-financial companies affected by the (...)
303
On 3 April, the Commission adopted an Amendment to extend the Temporary Framework for State aid measures to support the economy in the COVID-19 outbreak adopted on 19 March (covered in our previous alert : European Commission publishes its emergency COVID-19 State aid rules and rapidly approves (...)
217
The European Commission has now adopted a Framework of temporary State aid rules enabling Member States to adopt measures to support the growing number of businesses suffering because of the COVID-19 outbreak. This is the first time since the 2008 financial crisis that the Commission has (...)
342
As the number of businesses around the EU affected by the COVID-19 outbreak grows, many Member States are considering or have announced substantial supporting packages in an effort to limit the impact of the outbreak on the economy. Across the EU, measures vary, from governmental loans and (...)
373
On 10 March 2020 the Court of Appeal upheld the Competition Appeal Tribunal’s (CAT) quashing of the Competition and Markets Authority’s (CMA) decision that Pfizer and Flynn Pharma (Flynn) had abused their dominant positions in the market by pricing their epilepsy drug unfairly. Among other (...)
541
On Thursday, 28 March, the European Court of Justice of the European Union (ECJ) annulled the General Court’s ruling and the European Commission’s decision on the EEG 2012 on the grounds that it was wrong to conclude that the funds generated by the EEG surcharge constituted State resources. In (...)
927
On 18 April 2018, the Competition and Markets Authority issued updated guidance on the appropriate amount of penalties to be imposed for infringements of competition law in the UK. This replaces the previous guidance issued by the Office of Fair Trading (which the CMA replaced in 2014) and (...)
16
On 9 November 1995, the Court of Justice gave its ruling on a reference from the Verwaltungsgericht Frankfurt am Main (Administrative Court of Frankfurt) on questions relating to the ability of national courts to grant interim relief in a form that effectively disapplied an act of the EU (...)
19 avenue Jean Aicard
75011 Paris, France
106 West 32nd Street, Suite 149
New York, NY, 10001, USA
563 Chiswick High Road
W4 3AY London, UK
